Who Paid My Doc
Bartolo Santiago Delgado
Nuclear Medicine Guaynabo, PR Medical Doctor
NPI 1649214263 CMS profile 120003
2 Carr 177, The Falls Apt. 303, Guaynabo, PR 00966
General payments
$125
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$13,325
Through program year 2023, Bartolo Santiago Delgado of Guaynabo, PR is reported in the CMS Open Payments database as having received $125 across 1 general payment and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $13,325 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 35th percentile of Nuclear Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $125 | 1 |
Beside peers
- Bartolo Santiago Delgado
- Nuclear Medicine median
- Middle half of Nuclear Medicine
- National median
In program year 2025, general payments to Bartolo Santiago Delgado were reported at $0. Among 197 Nuclear Medicine profiles paid that year, the median was $146 and the middle half received between $40 and $372.
Show as a table
| Year | Bartolo Santiago Delgado | Nuclear Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $125 | $54–$531 | $163 |
| 2020 | $0 | $99 | $34–$2,125 | $114 |
| 2021 | $0 | $96 | $22–$874 | $132 |
| 2022 | $0 | $102 | $38–$240 | $149 |
| 2023 | $125 | $123 | $51–$257 | $160 |
| 2024 | $0 | $121 | $51–$390 | $164 |
| 2025 | $0 | $146 | $40–$372 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 6 billing codesPaid by Medicare
$5,369
Medicare patients
87
Services billed
136
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 56% | |
| Ischemic heart disease | 44% | |
| Arthritis | 44% | |
| Heart failure | 34% | |
| Chronic kidney disease | 30% | |
| Osteoporosis | 26% | |
| Atrial fibrillation | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nuclear Medicine in Puerto Rico
Sandra Gracia Lopez
Nuclear Medicine · Caguas, PR
Carlos Garcia
Nuclear Medicine · San Juan, PR
Ricardo Santiago Montalvo
Nuclear Medicine · Aguadilla, PR
Carlos Jimenez
Nuclear Medicine · Rio Piedras, PR
Elba Orduna Acum
Nuclear Medicine · Manati, PR
Jose Melendez Maldonado
Nuclear Medicine · Caguas, PR
Related records
Nuclear Medicine in Puerto Rico
Practitioners in the same specialty and state, ranked by reported value.
All Nuclear Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Puerto Rico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.